Analysis TransCode Therapeutics, Inc. (RNAZ)
6/3/2024
Analysis of TransCode Therapeutics, Inc. (RNAZ)
TransCode Therapeutics, Inc. (RNAZ) has shown significant price volatility in recent days, with the price ranging from a low of 1.25 to a high of 6.84. The Relative Strength Index (RSI) values have been consistently high, indicating overbought conditions, which may suggest a potential reversal in the near future.The Moving Average Convergence Divergence (MACD) indicator has been positive, with the MACD line above the signal line, indicating bullish momentum. However, the MACD histogram has been decreasing, which could signal a potential weakening of the bullish trend.
In terms of moving averages, the Simple Moving Average (SMA), Exponential Moving Average (EMA), and Weighted Moving Average (WMA) have all been trending upwards, indicating a positive price trend.
Overall, TransCode Therapeutics, Inc. shows signs of bullish momentum but with overbought conditions. Traders and investors should closely monitor the RSI levels and the MACD histogram for potential reversal signals.
Earnings
The company's results for the most recent quarter, ending on April 30, 2025, have not been provided at this time. The previous quarter's results, ending on February 27, 2025, were handled by the Transfer Agent. The quarter before that, ending on January 31, 2025, had results released after hours. The results for the quarter ending on October 31, 2024, were not provided at the time. However, for the quarter ending on August 1, 2024, the company had an EPS estimate of 1.32.Main Statystic ðŸ§
The data provided includes financials, stock statistics, valuation metrics, stock price summary, and dividends and splits information for a specific company.In terms of financials, the company has strong operating cash flow and levered free cash flow, with a healthy balance sheet showing a current ratio slightly above 1. The profit margin and operating margin are also favorable, indicating efficient operations. The company's fiscal year ends in September 2023, and the most recent quarter reported is March 2024. The company shows good returns on assets and equity.
Looking at stock statistics, the short ratio is low, and the percentage held by institutions is relatively high. The stock has a beta above 1, indicating higher volatility compared to the market. The stock price has fluctuated between a fifty-two-week low and high, with a positive change over the period.
Valuation metrics show a relatively high PEG ratio and forward P/E ratio. The company's market capitalization and enterprise value are significant, with a high price-to-book ratio and price-to-sales ratio. The company's enterprise value relative to EBITDA and revenue is also notable.
Lastly, dividends and splits information reveal details about the company's dividend payments, including payout ratio, dividend dates, and dividend yields. The company has a history of dividend payments and a recent stock split in 2020.
Income statement 💸
These are the revenues. Here are the conclusions:1. The company's sales revenue has been increasing steadily over the past four fiscal years.
2. The gross profit margin seems to be consistent, indicating stable cost management.
3. Net income has also shown a positive trend, reflecting the company's profitability.
4. Earnings per share (EPS) have been relatively stable over the years.
5. Operating income and EBITDA have also been increasing, showing operational efficiency.
6. The company has been able to maintain a healthy EBIT margin, indicating good operational performance.
7. The company's tax expenses have also increased in line with the growth in revenue and income.
8. Overall, the financial performance of the company seems to be strong and improving year over year.
Balance Sheet
These are balance sheets. Here are the conclusions:1. The total assets have been increasing over the years, reaching $365,725,000,000 in 2018.
2. Current assets have fluctuated, with the highest value in 2019 at $162,819,000,000.
3. Non-current assets have shown an increasing trend, with the highest value in 2019 at $175,697,000,000.
4. Total liabilities have also been increasing, reaching $255,355,000,000 in 2018.
5. Shareholders' equity has shown an increasing trend, with the highest value in 2018 at $107,147,000,000.
6. The company has been investing more in non-current assets over the years.
7. There has been a decrease in retained earnings from 2018 to 2023.
8. The company has been relying more on long-term debt to finance its operations.
9. Cash and cash equivalents have fluctuated over the years, with the highest value in 2019 at $48,844,000,000.
10. The company has been maintaining a significant amount of short-term investments.
Cash Flow 💶
This is the cash flow statement. Here are some conclusions we can draw from the data:1. The company's free cash flow has been fluctuating over the years, with the highest value in 2022 and the lowest in 2020.
2. Operating cash flow has generally been increasing year over year, indicating improved operational efficiency.
3. The company has been consistently paying interest and income taxes, with varying amounts each year.
4. The end cash position has also been fluctuating, reaching its highest value in 2020.
5. Financing activities show a pattern of common stock repurchase, issuance of long-term debt, and payment of dividends.
6. Investing activities include the sale and purchase of investments, as well as capital expenditures.
7. Overall, the company seems to be managing its cash flow effectively, with some fluctuations in different areas that may require further analysis.
Earnings estimate
Based on the analysts' estimates for future quarterly and annual earnings per share:1. For the current quarter ending on June 30, 2024, the average estimated EPS is $1.23, with a low estimate of $1.18 and a high estimate of $1.26. This shows an improvement compared to the EPS of $1.17 from the same quarter a year ago.
2. For the next quarter ending on September 30, 2024, the average estimated EPS is $1.42, with a low estimate of $1.33 and a high estimate of $1.51. This also indicates growth from the EPS of $1.35 in the same quarter last year.
3. Looking at the estimates for the current year ending on September 30, 2024, the average EPS is projected to be $6.10, ranging from a low estimate of $5.95 to a high estimate of $6.41. This reflects an increase from the EPS of $5.67 for the previous year.
4. For the next year ending on September 30, 2025, analysts forecast an average EPS of $6.69, with a low estimate of $5.92 and a high estimate of $7.31. This suggests a slight improvement from the EPS of $6.10 in the previous year.
Overall, the analysts' estimates indicate a positive outlook for the company's earnings per share, with expected growth in both the short term and the long term.
Revenue estimate
Based on the analysts' estimates for the future quarterly and annual sales of the company, we can draw the following conclusions:1. For the current quarter ending on June 30, 2024, the average sales estimate is $77,545,400,000, with a sales growth of 2% compared to the same quarter last year. The number of analysts providing estimates is 25.
2. For the next quarter ending on September 30, 2024, the average sales estimate is $85,501,800,000, with a sales growth of 3% compared to the same quarter last year. The number of analysts providing estimates is 25.
3. For the current fiscal year ending on September 30, 2024, the average sales estimate is $357,772,000,000, with a sales growth of 1% compared to the previous fiscal year. The number of analysts providing estimates is 38.
4. For the next fiscal year ending on September 30, 2025, the average sales estimate is $380,772,000,000, with a sales growth of 6% compared to the current fiscal year. The number of analysts providing estimates is 38.
These estimates indicate a generally positive outlook for the company, with expected growth in both quarterly and annual sales over the coming periods.
Growth estimates
Based on the consensus estimates provided by analysts, we can draw the following conclusions regarding the growth rate of the company for different periods:1. Current Quarter: The estimated growth rate for the current quarter is 5.1%.
2. Next Quarter: The estimated growth rate for the next quarter is 5.2%.
3. Current Year: The estimated growth rate for the current year is 7.6%.
4. Next Year: The estimated growth rate for the next year is 9.7%.
5. Past 5 Years (per annum): The average annual growth rate for the past 5 years is 20.1%.
6. Next 5 Years (per annum): The estimated average annual growth rate for the next 5 years is 9.7%.
These estimates suggest that the company has been experiencing strong growth in the past, and analysts expect this growth to continue at a slightly lower but still healthy rate in the coming years.
Price target
The analysts' forecast for the future price of the security is as follows:- Low: $164
- High: $275
- Median: $201.43
- Average: $204.58
- Current price: $192.25
- Currency: USD
Based on these forecasts, we can see that the analysts have a range of opinions on the future price of the security, with the low end at $164, the high end at $275, and the average forecast at $204.58. The current price of the security is $192.25, which is below the average and median forecasted prices. Investors should consider these forecasts along with other factors when making investment decisions.
MACD of RNAZ
This is not investment advice. Remember to verify the information provided here.
Get access to the full analysis
- Over 35 000 indexes
- CFD, Forex, Crypto and Stocks Exchange
- Over 150 Indicators
- Pattern and candle analysis
- Support and resistance levels
- Fundamental, technical and sentimental analysis
- Power from AI
